Oct 14, 2015_Bone and Mineral Metabolism PR

Related Posts

• AFTER A LACKLUSTER LAUNCH, KERYX’S AURYXIA APPEARS TO BE MOVING IN THE RIGHT DIRECTION ACCORDING TO SPHERIX GLOBAL INSIGHTS GMBH

  Oct 14, 2015 – Zug, Switzerland - Feedback gathered from300 US nephrologists inthe last three releases of RealTime Dynamix: Bone…

• NEPHROLOGISTS AND CARDIOLOGISTS EAGER FOR NEW AGENTS TO TREAT HYPERKALEMIA

  Relypsa’s Patiromer FOS and ZS Pharma’s ZS-9 could revolutionize the way hyperkalemia is managed according to Spherix Global Insights, GmbH…

• Preference, Persistency and Positioning for Lilly’s Taltz in Psoriasis Highlight a Potential Challenge Ahead for Novartis’ Cosentyx in PsO and Psoriatic Arthritis

  Spherix Global Insights has released the results of two independent surveys of dermatologists (n=100) and rheumatologists (n=100) about the evolving…